Anthropic's Potential $1.2 Trillion IPO Could Boost Stock
As Anthropic eyes an IPO, a potential $1.2 trillion valuation could ripple through AI stocks. This piece breaks down ...
An overview of potential yields from stablecoins, including yield farming, interest accounts, and risk considerations to optimize income.
27,570 articlesAs Anthropic eyes an IPO, a potential $1.2 trillion valuation could ripple through AI stocks. This piece breaks down ...
Eli Lilly has enjoyed rapid growth from GLP-1 drugs, but sky-high expectations invite questions about valuations. Thi...
A flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
The (nrxp) 2026 earnings call highlights a shifting biotech landscape. This article breaks down what the results mean...
Crypto markets rebound as ripple’s (xrp) potential and Solana price outlook draw attention. Key on-chain data and ins...
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
As demand for nickel, copper, cobalt, and manganese grows, TMC faces a pivotal path. This article breaks down two maj...
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
SpaceX's move toward a public market future brings questions about lockups. This guide explains spacex lockup period:...
A big order from China could reshape Boeing's outlook and affect your investments. This guide breaks down the implica...